David B. Musket, Director at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 25,000 shares at $3.10 ($78K) on 2017-05-09, disclosed to the SEC on 2017-05-11.
Open-market purchase of $78k CAPR by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Nothing distinguishes this filing.
| Filing → |
| CAPR | BUY | 2023-10-06 | $7K | — | Filing → |
| CAPR | SELL | 2022-07-01 | $213K | — | Filing → |
| CAPR | SELL | 2022-06-29 | $79K | — | Filing → |